1. Home
  2. SMX vs AIMD Comparison

SMX vs AIMD Comparison

Compare SMX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$13.76

Market Cap

19.7M

Sector

Technology

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.86

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMX
AIMD
Founded
N/A
1984
Country
Ireland
United States
Employees
19
41
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
17.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SMX
AIMD
Price
$13.76
$1.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
111.0K
983.0K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.45
52 Week High
$490.00
$4.50

Technical Indicators

Market Signals
Indicator
SMX
AIMD
Relative Strength Index (RSI) 56.73 46.93
Support Level $7.19 $1.77
Resistance Level $20.06 $2.51
Average True Range (ATR) 2.11 0.23
MACD -0.14 -0.04
Stochastic Oscillator 23.36 12.53

Price Performance

Historical Comparison
SMX
AIMD

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: